SWITCHBACK BIO Trademark

Trademark Overview


On Friday, April 12, 2019, a trademark application was filed for SWITCHBACK BIO with the United States Patent and Trademark Office. The USPTO has given the SWITCHBACK BIO trademark a serial number of 88383848. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 7, 2022. This trademark is owned by ElevateBio, LLC. The SWITCHBACK BIO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical anti-allergic preparations and substances; Pharmaceutical preparations for the prevention of Cancer and Acute and Chronic Devastating Diseases and Conditions beyond Cancer; Pharmaceutical preparations for the treatment and prevention of Cancer and Acute and Chronic Devastating Diseases and Conditions beyond Cancer; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of Cancer and Acute and Chronic Devastating Diseases and Conditions beyond Cancer; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for Cancer and Acute and Chronic Devastating Diseases and Conditions beyond Cancer; Pharmaceutical preparations, namely, antivirals; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatmen...
switchback bio

General Information


Serial Number88383848
Word MarkSWITCHBACK BIO
Filing DateFriday, April 12, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 7, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 6, 2019

Trademark Statements


Goods and ServicesPharmaceutical anti-allergic preparations and substances; Pharmaceutical preparations for the prevention of Cancer and Acute and Chronic Devastating Diseases and Conditions beyond Cancer; Pharmaceutical preparations for the treatment and prevention of Cancer and Acute and Chronic Devastating Diseases and Conditions beyond Cancer; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of Cancer and Acute and Chronic Devastating Diseases and Conditions beyond Cancer; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for Cancer and Acute and Chronic Devastating Diseases and Conditions beyond Cancer; Pharmaceutical preparations, namely, antivirals; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceuticals, namely, anti-infectives; Antibacterial pharmaceuticals; Biometallic compounds being a component in pharmaceutical preparations for Cancer and Acute and Chronic Devastating Diseases and Conditions beyond Cancer; Chemical preparations for pharmaceutical or medical purposes, namely, for Cancer and Acute and Chronic Devastating Diseases and Conditions beyond Cancer; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of a pill or capsule that facilitate the delivery of pharmaceutical preparations; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Therapeutic pharmaceutical for the treatment of Cancer and Acute and Chronic Devastating Diseases and Conditions beyond Cancer
Disclaimer with Predetermined Text"BIO"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 30, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameElevateBio, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressCambridge, MA 02142

Party NameElevateBio, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Monday, November 7, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 7, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, March 22, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 21, 2022SOU EXTENSION 5 GRANTED
Thursday, March 17, 2022SOU EXTENSION 5 FILED
Thursday, March 17, 2022TEAS EXTENSION RECEIVED
Thursday, September 23, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 21, 2021SOU EXTENSION 4 GRANTED
Tuesday, September 21, 2021SOU EXTENSION 4 FILED
Tuesday, September 21, 2021TEAS EXTENSION RECEIVED
Thursday, June 10, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 10, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 10, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, May 7, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 6, 2021SOU EXTENSION 3 GRANTED
Thursday, April 1, 2021SOU EXTENSION 3 FILED
Tuesday, May 4, 2021NOTICE OF REVIVAL - E-MAILED
Monday, May 3, 2021EXTENSION RECEIVED WITH TEAS PETITION
Monday, May 3, 2021PETITION TO REVIVE-GRANTED
Monday, May 3, 2021TEAS PETITION TO REVIVE RECEIVED
Monday, May 3, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 3, 2021ABANDONMENT - NO USE STATEMENT FILED
Friday, December 11, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 10, 2020SOU EXTENSION 2 GRANTED
Thursday, October 1, 2020SOU EXTENSION 2 FILED
Tuesday, November 3, 2020NOTICE OF REVIVAL - E-MAILED
Tuesday, November 3, 2020EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, November 3, 2020PETITION TO REVIVE-GRANTED
Tuesday, November 3, 2020TEAS PETITION TO REVIVE RECEIVED
Monday, November 2, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 2, 2020ABANDONMENT - NO USE STATEMENT FILED
Saturday, July 11, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 10, 2020SOU EXTENSION 1 GRANTED
Wednesday, April 1, 2020SOU EXTENSION 1 FILED
Friday, July 10, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, June 15, 2020NOTICE OF REVIVAL - E-MAILED
Saturday, June 13, 2020EXTENSION RECEIVED WITH TEAS PETITION
Saturday, June 13, 2020PETITION TO REVIVE-GRANTED
Saturday, June 13, 2020TEAS PETITION TO REVIVE RECEIVED
Monday, June 8, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 8, 2020ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 1, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 6, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 6, 2019PUBLISHED FOR OPPOSITION
Wednesday, July 17, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, June 29, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 25, 2019EXAMINER'S AMENDMENT ENTERED
Tuesday, June 25, 2019ASSIGNED TO LIE
Tuesday, June 25, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, June 25, 2019EXAMINERS AMENDMENT E-MAILED
Tuesday, June 25, 2019EXAMINERS AMENDMENT -WRITTEN
Saturday, June 22, 2019ASSIGNED TO EXAMINER
Tuesday, April 30, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, April 16, 2019NEW APPLICATION ENTERED IN TRAM